Sui-Yuan Chang to Humans
This is a "connection" page, showing publications Sui-Yuan Chang has written about Humans.
Connection Strength
0.052
-
Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses. Sci Rep. 2021 04 22; 11(1):8692.
Score: 0.008
-
Cost-effectiveness of detection of intestinal amebiasis by using serology and specific-amebic-antigen assays among persons with or without human immunodeficiency virus infection. J Clin Microbiol. 2008 Sep; 46(9):3077-9.
Score: 0.003
-
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. mBio. 2021 08 31; 12(4):e0058721.
Score: 0.002
-
Evolution of SARS-CoV-2 neutralizing antibody in an HIV-positive patient with COVID-19. J Formos Med Assoc. 2021 Dec; 120(12):2186-2190.
Score: 0.002
-
Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Antimicrob Agents Chemother. 2021 03 18; 65(4).
Score: 0.002
-
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan. J Formos Med Assoc. 2021 Jul; 120(7):1459-1463.
Score: 0.002
-
Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing. ACS Nano. 2021 01 26; 15(1):857-872.
Score: 0.002
-
Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection. EMBO Mol Med. 2021 01 11; 13(1):e12828.
Score: 0.002
-
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. Cell Rep. 2020 10 13; 33(2):108254.
Score: 0.002
-
Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. J Formos Med Assoc. 2021 May; 120(5):1269-1273.
Score: 0.002
-
The origin and underlying driving forces of the SARS-CoV-2 outbreak. J Biomed Sci. 2020 Jun 07; 27(1):73.
Score: 0.002
-
A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response. Int J Infect Dis. 2020 Jul; 96:464-466.
Score: 0.002
-
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients. J Infect. 2020 08; 81(2):e55-e58.
Score: 0.002
-
Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. 2020 08; 81(2):318-356.
Score: 0.002
-
The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient. J Infect. 2020 07; 81(1):147-178.
Score: 0.002
-
Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
Score: 0.002
-
Molecular epidemiology of acute HCV infection in HIV-positive patients from Hong Kong, Taipei, Tokyo. Liver Int. 2019 06; 39(6):1044-1051.
Score: 0.002
-
Dolutegravir-rilpivirine coformulation. Curr Opin HIV AIDS. 2018 07; 13(4):320-325.
Score: 0.002
-
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice. PLoS One. 2018; 13(2):e0192740.
Score: 0.002
-
Neutralizing antiinterferon-? autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy. AIDS. 2017 11 28; 31(18):2557-2559.
Score: 0.001
-
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy. Sci Rep. 2017 11 23; 7(1):16187.
Score: 0.001
-
Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey. BMJ Open. 2017 Oct 16; 7(10):e015142.
Score: 0.001
-
Long-term Durability of Responses to 2 or 3 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus-Positive Adults on Antiretroviral Therapy. J Infect Dis. 2017 02 15; 215(4):606-613.
Score: 0.001
-
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection. PLoS One. 2016; 11(12):e0169228.
Score: 0.001
-
Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: incidence and associated factor. J Infect Chemother. 2014 Aug; 20(8):465-70.
Score: 0.001
-
Entamoeba histolytica infection in men who have sex with men. Lancet Infect Dis. 2012 Sep; 12(9):729-36.
Score: 0.001
-
Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol. 2012 Mar; 50(3):781-7.
Score: 0.001
-
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2007 Nov 01; 45(9):1221-9.
Score: 0.001